Compare Duolingo Inc (DUOL) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duolingo Inc vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Duolingo Inc trades at $138.19 (market cap $6.54B), while GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 4.7× Duolingo Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Duolingo Inc pays none. Which is the better fit depends on your goals.
| DUOL | GEHC | |
|---|---|---|
Market Cap | $6.54B | $30.93B |
Volume | 985,128 | 5,033,451 |
Sector | Technology | Health |
52-Week High | $341.08 | $88.16 |
52-Week Low | $90.03 | $59.48 |
Typical Hold Time | 138 Days | — |
Enterprise Value | $5.31B | $39.39B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duolingo (DUOL) trades at $140.1, down 5.17% over the past day, amid mixed technical signals but strong fundamental performance. The stock shows a bullish moving average trend and neutral oscillators, with key support near $143. Financially, the company reported robust revenue growth, reaching $1.04 billion in 2025, with a net income margin of 35.87% and consistent earnings beats in recent quarters. Recent news highlights CEO share sales and AI-driven growth initiatives, contributing to investor attention.
The outlook for DUOL remains positive given its earnings momentum and expanding user base, though risks include insider selling and competitive pressures. Analyst consensus leans bullish with a $142.50 price target, suggesting modest upside from current levels, supported by institutional interest and solid cash flow generation.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
